ZIVO Bioscience (ZIVO) Competitors $14.49 0.00 (0.00%) As of 08/8/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock ZIVO vs. CRGX, NLTX, IPHA, ENGN, AVTE, MDWD, GNFT, VYGR, VTYX, and DMACShould you be buying ZIVO Bioscience stock or one of its competitors? The main competitors of ZIVO Bioscience include CARGO Therapeutics (CRGX), Neoleukin Therapeutics (NLTX), Innate Pharma (IPHA), enGene (ENGN), Aerovate Therapeutics (AVTE), MediWound (MDWD), GENFIT (GNFT), Voyager Therapeutics (VYGR), Ventyx Biosciences (VTYX), and DiaMedica Therapeutics (DMAC). These companies are all part of the "pharmaceutical products" industry. ZIVO Bioscience vs. Its Competitors CARGO Therapeutics Neoleukin Therapeutics Innate Pharma enGene Aerovate Therapeutics MediWound GENFIT Voyager Therapeutics Ventyx Biosciences DiaMedica Therapeutics CARGO Therapeutics (NASDAQ:CRGX) and ZIVO Bioscience (NASDAQ:ZIVO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and risk. Is CRGX or ZIVO more profitable? ZIVO Bioscience's return on equity of 0.00% beat CARGO Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets CARGO TherapeuticsN/A -43.21% -37.26% ZIVO Bioscience N/A N/A -2,240.92% Do institutionals and insiders believe in CRGX or ZIVO? 93.2% of CARGO Therapeutics shares are owned by institutional investors. Comparatively, 12.8% of ZIVO Bioscience shares are owned by institutional investors. 2.9% of CARGO Therapeutics shares are owned by insiders. Comparatively, 48.9% of ZIVO Bioscience shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has more volatility and risk, CRGX or ZIVO? CARGO Therapeutics has a beta of 0.3, meaning that its share price is 70% less volatile than the S&P 500. Comparatively, ZIVO Bioscience has a beta of -0.06, meaning that its share price is 106% less volatile than the S&P 500. Does the media favor CRGX or ZIVO? In the previous week, CARGO Therapeutics had 5 more articles in the media than ZIVO Bioscience. MarketBeat recorded 5 mentions for CARGO Therapeutics and 0 mentions for ZIVO Bioscience. CARGO Therapeutics' average media sentiment score of 0.98 beat ZIVO Bioscience's score of 0.00 indicating that CARGO Therapeutics is being referred to more favorably in the media. Company Overall Sentiment CARGO Therapeutics Positive ZIVO Bioscience Neutral Which has better valuation and earnings, CRGX or ZIVO? ZIVO Bioscience has higher revenue and earnings than CARGO Therapeutics. ZIVO Bioscience is trading at a lower price-to-earnings ratio than CARGO Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCARGO TherapeuticsN/AN/A-$167.50M-$4.62-0.97ZIVO Bioscience$15.85K3,489.48-$7.78M-$4.93-2.94 Do analysts prefer CRGX or ZIVO? CARGO Therapeutics presently has a consensus target price of $15.40, indicating a potential upside of 242.98%. Given CARGO Therapeutics' stronger consensus rating and higher probable upside, research analysts plainly believe CARGO Therapeutics is more favorable than ZIVO Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CARGO Therapeutics 1 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.86ZIVO Bioscience 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryCARGO Therapeutics beats ZIVO Bioscience on 9 of the 13 factors compared between the two stocks. Get ZIVO Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for ZIVO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ZIVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZIVO vs. The Competition Export to ExcelMetricZIVO BioscienceBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$55.31M$289.09M$5.52B$9.72BDividend YieldN/AN/A4.60%4.12%P/E Ratio-2.97N/A30.0124.75Price / Sales3,489.48462.25450.0597.82Price / CashN/A22.4436.7758.47Price / Book-17.898.908.185.59Net Income-$7.78M-$115.81M$3.26B$265.99M7 Day Performance45.34%-2.68%6.13%5.06%1 Month Performance7.33%-8.15%0.07%0.61%1 Year Performance61.00%-4.26%36.31%22.82% ZIVO Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZIVOZIVO BioscienceN/A$14.49flatN/A+61.0%$55.31M$15.85K-2.9710Upcoming EarningsCRGXCARGO Therapeutics2.4673 of 5 stars$4.47-0.3%$15.40+244.9%-67.9%$205.88MN/A-0.97116Positive NewsUpcoming EarningsNLTXNeoleukin TherapeuticsN/A$21.72-0.3%N/A-40.4%$204.13MN/A-6.9890Gap UpIPHAInnate Pharma2.326 of 5 stars$2.18+3.3%$11.00+404.6%-3.5%$200.95M$21.77M0.00220News CoverageENGNenGene3.2968 of 5 stars$3.90+2.1%$23.29+497.1%-44.3%$200.26MN/A-2.3831AVTEAerovate TherapeuticsN/A$6.89-4.2%N/A-87.3%$199.71MN/A-2.3020Upcoming EarningsHigh Trading VolumeMDWDMediWound1.9949 of 5 stars$18.24-0.7%$32.25+76.8%+3.2%$197.14M$19.21M-8.7380Upcoming EarningsGNFTGENFIT1.578 of 5 stars$3.94+3.8%$13.00+230.4%-4.6%$196.75M$76.77M0.00120Gap UpVYGRVoyager Therapeutics3.8906 of 5 stars$3.56+10.8%$13.39+276.4%-54.6%$195.07M$80M-2.41100Earnings ReportAnalyst ForecastAnalyst RevisionVTYXVentyx Biosciences2.75 of 5 stars$2.70-0.7%$10.00+270.1%+35.7%$193.91MN/A-1.5630News CoverageEarnings ReportUpcoming EarningsAnalyst UpgradeGap UpDMACDiaMedica Therapeutics1.734 of 5 stars$4.51+3.4%$10.75+138.4%+31.5%$193.17MN/A-7.0420 Related Companies and Tools Related Companies CRGX Alternatives NLTX Alternatives IPHA Alternatives ENGN Alternatives AVTE Alternatives MDWD Alternatives GNFT Alternatives VYGR Alternatives VTYX Alternatives DMAC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ZIVO) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredAltucher: $900 to $108,000? Trump’s “Great Gain” Is HereJames Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump poli...Paradigm Press | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZIVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZIVO Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZIVO Stock Alerts